Kantonsspital Winterthur

Winterthur, Switzerland

We are delighted to announce that Kantonsspital Winterthur in Switzerland has been recognized as an IASIOS Centre of Excellence, joining a growing group of leading institutions worldwide that have achieved this prestigious distinction.

The Centre of Excellence designation represents the highest level of recognition within IASIOS, confirming that Kantonsspital Winterthur meets both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

This achievement reflects a fully integrated and meticulously structured interventional oncology pathway, ensuring that every patient receives consistent, safe, and high-quality care. From staff competence and multidisciplinary collaboration to facility infrastructure and radiation safety, Kantonsspital Winterthur demonstrates excellence across every aspect of its IO service.

We commend the dedication and leadership of Dr. Arash Najafi, Ms. Annmarie Monard, Mr. Patrick Martin, and Mr. Johannes Lauinger, whose commitment to quality and patient-centred care has been instrumental in reaching this milestone.

Their accomplishment marks a significant contribution to advancing standards in interventional oncology and stands as an inspiration to the global IO community.

Dr. Arash Najafi

IASIOS Council Member

(Kantonsspital Winterthur, Switzerland)

SLK Kliniken Heilbronn GmbH

Heilbronn, Germany

We are proud to announce that SLK Kliniken Heilbronn in Germany has been recognized as an IASIOS Centre of Excellence, becoming the third centre worldwide and the very first in Germany to achieve this distinction.

The Centre of Excellence designation is the highest level of recognition within IASIOS, confirming that SLK Kliniken Heilbronn fulfils both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. This recognition means that the entire interventional oncology patient pathway at the centre follows a systematic and structured approach, where every patient receives consistent and high-quality care. Staff competence, advanced facility infrastructure, precise treatment delivery, and rigorous standards of radiation safety are all upheld at the highest international level.

We commend the dedication and commitment of Prof. Pereira, Prof. Grözinger, Dr. Speck, Dr. Mayer, Mr. Hermann, Dr. Wandschneider and the entire interventional radiology team at SLK Kliniken Heilbronn. Their achievement represents an outstanding contribution to clinical quality in interventional oncology and serves as an inspiration to the global IO community.

Dr. Sina Speck

IASIOS Council Member

(SLK-Kliniken Heilbronn, Germany)

Singapore General Hospital

Singapore

We are pleased to announce that Singapore General Hospital has been recognised as an IASIOS Centre of Excellence, becoming the first in Asia and only the second worldwide to achieve this distinction.

This milestone reflects the hospital’s strong commitment to delivering high-quality, patient-centred interventional oncology services, aligned with the most rigorous international standards. It also marks a significant step forward for the field, as leading institutions across Asia continue to shape the global landscape of IO practice.

We extend our sincere congratulations to Prof. Kiang Hiong Tay, Prof. Bien Soo Tan, Dr. Farah Irani, Dr. Sonam Tashi, Dr. Chandramohan Sivanathan, A/Prof Too Chow Wei, Mr. Loke Jiun Siong, Ms. Joyce Liu, Ms. Agnes Wong, Ms. Yap Siew Kuan, and Ms. Arjunana Sarupraba — as well as the entire radiology team — for their dedication to excellence and continuous improvement.

Being designated a Centre of Excellence means fulfilling both the core and extended CIRSE Standards of Quality Assurance in Interventional Oncology. These standards, supported by over 40 national and international societies, including the European Cancer Organisation, set a comprehensive framework for delivering safe, consistent, and high-quality care.

We congratulate Singapore General Hospital on this remarkable achievement and look forward to its continued leadership in interventional oncology.

Prof. Bien-Soo Tan

IASIOS Council Member

(Singapore General Hospital, Singapore)

Dr. Farah Irani

IASIOS Council Member

(Singapore General Hospital, Singapore)

Strasbourg University Hospitals

Strasbourg, France

Prof. Afshin Gangi and his team at Strasbourg University Hospitals have become the first to achieve the Centre of Excellence. This achievement is a testament to their remarkable clinical pathway and pioneering work in the field of IO.
Strasbourg University Hospitals has been a valuable member of IASIOS since the pilot phase. As early adopters, they were among the first to achieve accreditation and are now the first to achieve the highest seal of accreditation in interventional oncology, the IASIOS Centre of Excellence.

Members of the IASIOS Steering Board and Council

Prof. Afshin Gangi

IASIOS Steering Board Member

(Strasbourg, France)

Dr. Roberto Luigi Cazzato

IASIOS Council Member

(Strasbourg University Hospital, France)